This is the authors' abstract. We don't add key points for this paper.
Crimean-Congo hemorrhagic fever (CCHF), a tick-borne viral hemorrhagic fever, is a zoonotic infection that caused byCCHF virus (CCHFV) of the family Bunyaviridae, genus Nairovirus. Transmission occurs mainly by Hyalomma m. marginatumtick exposure. Blood and bloody excretions of the patients are highly infectious and contact of skin and mucousmembrane may lead to CCHF transmission. CCHF was described firstly in the Crimean peninsula in 1944, in former SovietUnion and in Kelkit Valley in 2002 in Turkey. By the year 2013, it has been notified in more than 30 countries of Asia,the Middle East, Southeastern part of Europe and Africa. The disease is characterized by fever and thrombocytopenia,in severe cases, hemorrhage and shock. Although, the case fatality rate for the infection is generally ranged from 10 to50%, it was reported as 5% for Turkey. Main targets of CCHFV are immune cells and endothelium. Both innate and adaptiveimmunity are important for fighting against CCHFV in the host. Headache, fever, fatigue and muscle, joint pain, conjunctivalinjection, facial hyperemia, thrombocytopenia, elevated liver enzymes, hepatomegaly and splenomegaly arethe main symptoms and findings for CCHF. Hemorrhagic manifestations including ecchymosis, melena, hematochezia,hematemesis, and epistaxis are commonly seen in severe cases. Supportive treatment is essential and nowadays neithera special drug, nor safe vaccine for humans is available for the treatment and prevention of CCHF. In case of penetratinginjury with contaminated material, the oral ribavirin prophylaxis may be offered after the area being washed with soapywater and ethanol.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Elaldı et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: